Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials.

Ebell MH, Call M, Shinholser J.

Fam Pract. 2013 Apr;30(2):125-33. doi: 10.1093/fampra/cms059. Epub 2012 Sep 20. Review.

PMID:
22997224
2.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ.

Cochrane Database Syst Rev. 2014 Apr 10;(4):CD008965. doi: 10.1002/14651858.CD008965.pub4. Review.

PMID:
24718923
3.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD008965.

PMID:
22258996
4.

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.

Dobson J, Whitley RJ, Pocock S, Monto AS.

Lancet. 2015 May 2;385(9979):1729-37. doi: 10.1016/S0140-6736(14)62449-1. Epub 2015 Jan 30. Review. Erratum in: Lancet. 2015 May 2;385(9979):1728. Lancet. 2015 May 2;385(9979):1728.

5.

Neuraminidase inhibitors for preventing and treating influenza in children.

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002744.

PMID:
22258949
6.

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ.

BMJ. 2014 Apr 9;348:g2545. doi: 10.1136/bmj.g2545. Review.

8.

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Sch√ľnemann HJ.

Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27. Review.

PMID:
22371849
9.

Neuraminidase inhibitors for preventing and treating influenza in children.

Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.

Cochrane Database Syst Rev. 2003;(3):CD002744. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD002744.

PMID:
12917931
10.

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.

Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K.

Health Technol Assess. 2009 Feb;13(11):iii, ix-xii, 1-246. doi: 10.3310/hta13110. Review.

11.

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.

Orzeck EA, Shi N, Blumentals WA.

Clin Ther. 2007 Oct;29(10):2246-55.

PMID:
18042482
12.

[A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza].

Li L, Cai B, Wang M, Zhu Y.

Zhonghua Nei Ke Za Zhi. 2001 Dec;40(12):838-42. Chinese.

PMID:
16206676
13.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults.

Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001265. doi: 10.1002/14651858.CD001265.pub3. Review.

PMID:
20166059
14.

Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

Peters PH, Moscona A, Schulman KL, Barr CE.

Medscape J Med. 2008 Jun 4;10(6):131.

15.

[A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].

Lin JT, Yu XZ, Cui DJ, Chen XY, Zhu JH, Wang YZ, Wu XD, Gao H, Huo ZL, Zhu SH, Hu SL, Wang AX.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):455-9. Chinese.

PMID:
15312558
16.

Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials.

Qiu S, Shen Y, Pan H, Wang J, Zhang Q.

Infect Dis (Lond). 2015;47(11):808-19. doi: 10.3109/23744235.2015.1067369. Epub 2015 Jul 15.

PMID:
26173991
17.
18.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
19.

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T.

BMJ. 2014 Apr 9;348:g2547. doi: 10.1136/bmj.g2547. Review.

20.

Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children.

Gums JG, Pelletier EM, Blumentals WA.

Expert Opin Pharmacother. 2008 Feb;9(2):151-61. doi: 10.1517/14656566.9.2.151 .

PMID:
18201141

Supplemental Content

Support Center